Rajeev A. Modi - 07 Mar 2025 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
11 Mar 2025, 17:13:04 UTC
Prior SEC filing
05 Mar 2025
Next SEC filing
25 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi

Key filing fact

Rajeev A. Modi filed Form 4 for Elanco Animal Health Inc (ELAN) on 11 Mar 2025.

Key facts

  • This page summarizes Rajeev A. Modi's Form 4 filing for Elanco Animal Health Inc (ELAN).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 11 Mar 2025, 17:13.

Change

  • Previous filing in this sequence was filed on 05 Mar 2025.
  • Current net transaction value: +$27,485.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELAN transaction Derivative

Deferred Stock Units

Award

Transaction value
$27,485
Shares
+2,467
Change %
+83%
Price
$11.14
Shares after
5,444
Date
07 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,467
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

Footnote F2

Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

SEC remarks

Executive Vice President U.S. Pet Health and Global Digital Transformation

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .